维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Ford MR"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Safety,tolerability,pharmacokinetics,and pharmacodynamics of irbesartan after single and multiple doese in healthy male subjects显示文摘	Marino MR Langenbacher KM Ford NF	1997	Clin Pharmacol Ther1997，61，：	1
2	Pharmacodynamics and pharmacokinetics of irbesartan in patients with mild to moderate hypertension 显示文摘	Marino MR Langenbacher KM Ford NE	1999	J Cardiovasc Pharmacol Ther1999，4，2：	1
3	Safety,tolerability,pharmacokinetics and pharmacodynamics of irbesartan after single and multiple dose in healthy male subjects显示文摘	Marino MR Langenbacher KM Ford NF	1997	Clin Pharmacol Ther1997，61，：	1
4	Biological and biome- chanical responses to traditional eplthelium-off and transepithelialriboflavin-UVA CXL techniques in rabbits 显示文摘	Armstrong BK Lin MP Ford MR	2013	J Refract Surg2013，29，5：	1
5	Oxazolidinone structure-activity relationships leading to linezolid显示文摘	Barbachyn MR Ford CW	2003	Angew Chem Int Ed Engl2003，42，18：	1
6	Oxazolidinone structure-activity relationships leading to linezolid显示文摘	Barbachyn MR Ford CW	2003	Angew Chem Int Ed2003，42，：	1
7	Evaluation of investigation condueted to detect and prevent transmission of tubereulosis显示文摘	Reichler MR Reves R Bur S Thompson V Mangura BT Ford J Valway SE Onorato	2002	JAMA2002，287，8：	1
8	The clinical use of inflammatory markers duringpregnancy显示文摘	Genc MR Ford CE	2010	Curr Opin Obstet Gynecol2010，22，2：	1
9	Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects 显示文摘	Marino MR Langenbocher K Ford NF	1998	J Clin Pharmacol1998，38，3：	1
10	Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects 显示文摘	Marino MR Langenbacher K Ford NF	1998	Clin Pharmacol1998，38，2：	1
11	Pharmacokinetics and Pharmacodynamics of irbesartan in Healthy subjects显示文摘	Marino MR Langenbocher K Ford NF	1998	J Clin Pharmacol1998，38，：	1
12	The clinical use of inflammatory markers during pregnancy显示文摘	Gen MR Ford CE	2010	Curt Opin Obstet Gynecol2010，22，2：	1
13	Pharmacokinetics and Pharmacodynamics of irbesartan inHealthy subjects 显示文摘	Marino MR LangenbocherK Ford NF	1998	J Clin Pharmacol1998，38，3：	1
14	Estimates of absorbed fractions for mono-energetic photon sources uniformly distributed in various organs of a heterogeneous phantom 显示文摘	Fisher HL Ford MR	1969	J Nucl Med1969，10，3：	1
15	Use of whole genome sequencing to estimate the mu- tation rate of Mycobacterium tuberculosis during latent infection 显示文摘	Ford CB Lin PL Chase MR Shah RR lartchouk O Galagan J Mohaideen N Ioerger TR Sacehettini JC Lipsitch M Flynn JL Fortune SM	2011	Nat Genet2011，43，5：	1
16	The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection显示文摘	Borgaonkar MR Ford DC Marshall JK	2006	Dig Dis Sci2006，51，5：	1
17	Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects显示文摘	Marino MR Langenbacher K Ford NF	1998	J Clin Pharmacol1998，38，3：	1
18	Tuberculosis and nutrition: disease perceptions and health seeking b ehavior of household contacts in the Peruvian Amazon显示文摘	Baldwin MR Yori PP Ford C	2004	Int J Tuberc Lung Dis2004，8，12：	1
19	Oxazolidinone structure-activity rela-tionships leading to linezolid显示文摘	Barbachyn MR Ford CW	2003	Angew Chem Int Ed Engl2003，42，：	1
20	Cell compartmentalisation in planctomycetes:novel types of structural organisation for the bacterial cell 显示文摘	Lindsay MR Webb RI Strous M Jetten MS Butler MK Forde RJ Fuerst JA	2001	Arch Microbiol2001，175，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示